Valid novel pyrrolodihydroisoquinoline in the treatment of cancer

2004 
The present invention relates to novel pyrrolodihydroisoquinoline derivatives, which are cells (excess) inducers of apoptosis in effective inhibitor and / or cancer cell growth.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []